.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Baxter
Healthtrust
Moodys
Fuji
Daiichi Sankyo
Accenture
Johnson and Johnson
Julphar

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062686

« Back to Dashboard
NDA 062686 describes TETRACYCLINE HYDROCHLORIDE, which is a drug marketed by Warner Chilcott, Abbott, Watson Labs, Ivax Sub Teva Pharms, Roxane, Alpharma Us Pharms, Sun Pharm Inds, Superpharm, Proter, Heather, Chartwell Tetra, Elkins Sinn, Hikma Pharms Llc, Impax Labs, Idt Australia Ltd, Valeant Pharm Intl, Ferrante, Mylan, Mast Mm, Wyeth Ayerst, Pvt Form, and Purepac Pharm, and is included in twenty-six NDAs. It is available from thirteen suppliers. Additional details are available on the TETRACYCLINE HYDROCHLORIDE profile page.

The generic ingredient in TETRACYCLINE HYDROCHLORIDE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

Summary for NDA: 062686

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength250MG
Approval Date:Jul 24, 1986TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength500MG
Approval Date:Jul 24, 1986TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Mallinckrodt
US Department of Justice
Harvard Business School
Julphar
Cerilliant
Baxter
Merck
Colorcon
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot